IMGN-151

N/A

Report date: 2026/03/31 14:52:46

Base Information

Drug NameIMGN-151
Drug Alias NameIMGN-151
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Linker > Cleavable linker > Cleavable peptide linkerBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Payload > DM21 payloadBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionApoptosis stimulantsTubulin polymerisation promotersMitosis inhibitors +[5] 
TargetsFolate receptor alphaTubulin
Therapy Area/IndicationsUterine Cervical NeoplasmsEndometrial NeoplasmsFallopian Tube Neoplasms +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[13] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesImmunogen Inc
China Registration ClassN/A

Develop Information

Active CompaniesImmunogen IncAbbvie Inc
Inactive CompaniesN/A
Active IndicationsUterine Cervical NeoplasmsEndometrial NeoplasmsFallopian Tube Neoplasms +[8] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A